QualityStocks Stock Newsletters Archives - Page 509 of 1818

MondayMay 24, 2010 10:19 am

Cellceutix Corp. (CTIX.OB) Moves Closer to Human Trials with Kevetrin™

Cellceutix Corp. announced today that they have reached agreements with PharPoint Reasearch and Medical Research Consulting Services for Phase 1 clinical trials of their lead compound, Kevetrin, which is being developed to target drug-resistant cancers. PharPoint will handle data management and statistical analysis while Medical Research will be responsible for clinical monitoring throughout the human trials. Art Holmes, President of PharPoint, was quoted in the press release as stating, “We are pleased to have the opportunity to work with Cellceutix and to bring our skills to bear on the Kevetrin Phase 1 study,” Mr. Holmes continued, “From a corporate standpoint,…

MondayMay 24, 2010 9:51 am

Arkanova Energy Corp. (AKVA.OB) Appoints Industry Veteran as Field Manager to Head Schlumberger Data-Supported Reactivation and Infield Drilling Program

Arkanova Energy Corp., www.arkanovaenergy.com - the Woodlands, TX-based oil and gas developer with three key North American sites in its portfolio, detailed the recent hiring of 15-year industry veteran Lance Nelson today in a press release. Nelson will be field manager of AKVA’s Two Medicine Cut Bank Sand Unit (TMCBSU - Cut Bank, Montana) and supervise the Company’s initiation of their Reactivation and Infield Drilling Program, which is being supported by Schlumberger's Data and Consulting Services (DCS) and is designed to put eight wells back into service, in addition to reactivating a production battery in the field’s south portion (due…

MondayMay 24, 2010 9:33 am

Shrink Nanotechnologies, Inc. (INKN.OB) Files Major Patent on Rapid Prototyping System

One company that is starting to capture the imagination of investors is Shrink Nanotechnologies, Inc. Located in Carlsbad, California, Shrink is a one-of-a-kind FIGA organization which focuses on leveraging contributions from experts in the fields of Finance, Industry, Government and Academia (FIGA). Today, Shrink took a major step towards enhancing its future with the announcement that their Biotech R & D Group has filed a patent on a rapid prototyping system for the manufacture of microfluidic chips, or Lab-on-a-Chip (LOC) devices. The patent will allow Shrink to make its presence felt in the biochip market which has evolved into a…

MondayMay 24, 2010 8:38 am

China Crescent Enterprises, Inc. (CCTR.OB) Video Chart for Monday, May 24, 2010

CCTR failed to make a big move a few weeks ago. It is now back down on a support level and we are looking for it to once again hold support and attempt a larger move. Please click the following link: http://www.qualitystocks.net/videocharts.php?chartvid_id=403 Let us hear your thoughts below:

MondayMay 24, 2010 6:56 am

Ecochild Inc. (ECOH.OB) Subsidiary Retains CCG Investor Relations for Campaign

Today, Ecochild Inc.’s wholly owned subsidiary, AIVtech Holding Limited, announced that it has contracted CCG Investor Relations for the design and execution of its investor relations campaign. The company utilizes its subsidiaries to manufacture and market its electronic furniture, digital/multimedia speakers, and LCD/LED televisions. Considered a fast-growing manufacturer of multimedia electronics, AIVtech’s 2009 revenues stem solely from the sales of electronic furniture and digital/multimedia speakers; the company reported revenues of $38.5 million, with a full-year 2009 net income of $7.5 million, an increase of 91.9% over 2008. JinLin Guo, AIVtech Chairman and CEO, commented, "We look forward to working with…

MondayMay 24, 2010 6:53 am

Divine Skin Inc. (DSKX.OB) Opens its First Day of Trading Up

Divine Skin Inc. announced on Friday, May 21, 2010, that they opened their first day of trading up at $0.30. The newly public company evolved out of their flagship brand, DS Laboratories. Growing quickly without investment capital until 2009, DS Laboratories then conducted a private placement. Founder and Chief Executive Officer, Mr. Daniel Khesin, said the Company's rapid expansion came through "exhaustive research, out-of-the-box thinking, and entrepreneurial drive." Divine Skin Inc. develops and markets cosmeceuticals under a few brands. DS Laboratories (DS) specializes in restoring growth and radiance to hair; suppressing dandruff and unwanted hair; balancing natural flora to enhance…

MondayMay 24, 2010 6:46 am

Manas Petroleum Corp. (MNAP.OB) Posts Q1 Results

Manas Petroleum Corp. recently filed and posted its first-quarter results for the three months ended March 31, 2010. The company reported net income of $83.0 million as compared to a net loss of $2.20 million for the first quarter of 2009. Manas Petroleum attributes the increase mainly to the $57.8 million gain from the sale of Manas Adriatic GmbH and a change in fair value of investment in associate of $28.8 million. Manas' operating expenses for the first quarter increased to $3.2 million as compared to $2.5 million for the same period in 2009. The company attributes the 29 percent…

MondayMay 24, 2010 6:44 am

Sorrento Therapeutics, Inc. (SRNE.OB) Receives Grant to Support Development of Staph Fighting Therapeutics

Sorrento Therapeutics Inc. Friday announced that it has received an Advanced Technology Small Business Technology Transfer Research (STTR) grant from the National Institute of Allergy and Infectious Diseases to assist Sorrento in its programs to generate and develop novel antibody therapeutics and vaccines to against Staphylococcus aureus (staph) infections. Phase I of the grant is for $300,000 annually for two years, with the possibility of phase II funding of $1 million per year for up to three years thereafter. According to the Centers for Disease Control and Prevention, in 2005 about 94,000 serious staph infections occurred in the U.S., resulting…

FridayMay 21, 2010 3:47 pm

Keyuan Petrochemicals, Inc. (SVPE) Reports Large Jump in Net Income and Revenue

Keyuan Petrochemicals, Inc. reported net income of $6.7 million in the first quarter of 2010, compared to a net loss of $8.8 million in the last quarter of 2009. Keyuan Petrochemicals, Inc. reported revenue of $117.4 million in the first quarter of 2010. The company had no revenue in the first quarter of 2009 as it began operations in October 2009. Revenues in the final quarter of 2009 came in at $68.7 million. Keyuan Petrochemicals, Inc. sold 144,746 metric tons of different petrochemical products in the first quarter of 2010. This represented a large sequential increase from the 96,690 metric…

FridayMay 21, 2010 3:45 pm

Spherix Inc. (SPEX) Reports Progress On Phase 3 Trial for Diabetes Drug

Spherix Inc. reported progress on a Phase 3 clinical trial for its new drug to treat Type 2 diabetes and expects results in the third quarter of 2010. Spherix is developing D-tagatose, which is used to reduce blood sugar levels in patients suffering from Type 2 diabetes. D-tagatose works by decreasing glycogen utilization in the body, which leads to better control of blood sugar. Spherix has two clinical trials underway for D-tagatose with the Food and Drug Administration (FDA) under the Investigational New Drug Application (NDA) format with the agency. The company has a Phase 2 trial to evaluate D-tagatose…

Site Search

Company Search

Category: QualityStocks Stock Newsletters